182 related articles for article (PubMed ID: 7860398)
21. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers.
Maciejewski B; Skladowski K; Zajusz A
Neoplasma; 1991; 38(5):513-22. PubMed ID: 1956467
[TBL] [Abstract][Full Text] [Related]
22. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.
Shibamoto Y; Streffer C
Cancer Res; 1991 Oct; 51(19):5134-8. PubMed ID: 1913638
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
24. Cell loss and the concept of potential doubling time.
Bertuzzi A; Gandolfi A; Sinisgalli C; Starace G; Ubezio P
Cytometry; 1997 Sep; 29(1):34-40. PubMed ID: 9298809
[TBL] [Abstract][Full Text] [Related]
25. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome.
Shibamoto Y; Ike O; Mizuno H; Fukuse T; Hitomi S; Takahashi M
Clin Cancer Res; 1998 Mar; 4(3):677-82. PubMed ID: 9533537
[TBL] [Abstract][Full Text] [Related]
26. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
27. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
[TBL] [Abstract][Full Text] [Related]
28. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
Petersen C; Zips D; Krause M; Schöne K; Eicheler W; Hoinkis C; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):483-93. PubMed ID: 11567825
[TBL] [Abstract][Full Text] [Related]
29. Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation.
Murata R; Nishimura Y; Shibamoto Y; Hiraoka M; Abe M
Jpn J Cancer Res; 1996 Jun; 87(6):662-8. PubMed ID: 8766532
[TBL] [Abstract][Full Text] [Related]
30. Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors.
Durand RE
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):803-8. PubMed ID: 9369126
[TBL] [Abstract][Full Text] [Related]
31. Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice.
Hessel F; Krause M; Petersen C; Hörcsöki M; Klinger T; Zips D; Thames HD; Baumann M
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):510-8. PubMed ID: 14751522
[TBL] [Abstract][Full Text] [Related]
32. [Effect of growth rate of monolayer cells on survival after fractionated irradiation].
Takemasa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1007-15. PubMed ID: 1508644
[TBL] [Abstract][Full Text] [Related]
33. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
34. Host cell cytotoxicity, cellular repopulation dynamics, and phase-specific cell survival in X-irradiated rat rhabdomyosarcoma tumors.
Tenforde TS; Kavanau KS; Afzal SM; Curtis SB
Radiat Res; 1990 Jul; 123(1):32-43. PubMed ID: 2371379
[TBL] [Abstract][Full Text] [Related]
35. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
36. Repopulation in murine skin after X-ray treatments with multiple fractions per day.
Tsang RW; Joiner MC; Rojas A; Johns H
Radiat Res; 1991 Feb; 125(2):163-72. PubMed ID: 1996374
[TBL] [Abstract][Full Text] [Related]
37. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
38. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
39. [Cell kinetics of human solid tumors and biological basis for fractionated radiotherapy].
Sasaki T; Mashiyama S
Gan No Rinsho; 1985 Sep; 31(12):1502-11. PubMed ID: 4079038
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
